gut.bmj3d
ECM1 attenuates hepatic fibrosis by interfering with mediators of latent TGF-β1 activation
Objective Extracellular matrix protein 1 (ECM1) serves as a gatekeeper of hepatic fibrosis by maintaining transforming growth ...
gut.bmj1d
Role of visceral sensitivity in the pathophysiology of irritable bowel syndrome
Visceral hypersensitivity has been recognised as a characteristic of patients with irritable bowel syndrome (IBS). It may be involved in the pathogenesis of abdominal pain/discomfort, and seems to ...
gut.bmj1d
Anthranoid laxative abuse--a risk for colorectal cancer?
Anthranoid-containing laxatives--aloe, cascara, frangula, and rheum--may play a role in colorectal cancer. This risk is particularly important in view of the wide abuse of self administered laxatives ...
gut.bmj1d
Heterozygous carriage of the alpha1-antitrypsin Pi*Z variant increases the risk to develop liver cirrhosis
Correspondence to Dr Thomas Berg, Section of Hepatology, Department of Internal Medicine, University Hospital Leipzig, Leipzig 04103, Germany; thomas.berg{at}medizin.uni-leipzig.de Objective ...
gut.bmj1d
An evidence-based appraisal of reflux disease management — the Genval Workshop Report
aDepartment of Gastrointestinal Medicine, Royal Adelaide Hospital, Adelaide, Australia, bSödra Hõlsocentralen, Hudiksvall, Sweden, cUniversity of Michigan Health ...
gut.bmj3d
Guidelines for follow up after resection of colorectal cancer
Correspondence to: Professor J H Scholefield, Department of Surgery, University Hospital, Nottingham NG7 2UH, UK; john.scholefield{at}nottingham.ac.uk Follow up after colorectal resection is a ...
gut.bmj7d
HBV infection-induced liver cirrhosis development in dual-humanised mice with human bone mesenchymal stem cell transplantation
Objective Developing a small animal model that accurately delineates the natural history of hepatitis B virus (HBV) infection and immunopathophysiology is necessary to clarify the mechanisms of ...
gut.bmj4d
Nerve growth factor and Trk high affinity receptor (TrkA) gene expression in inflammatory bowel disease
Dr Helmut Friess, Department of Visceral and Transplantation Surgery, University of Bern, Inselspital, CH-3010 Bern, Switzerland. Email: helmut.friess{at}insel.ch BACKGROUND Nerve growth factor (NGF), ...
gut.bmj2d
Non-alcoholic steatohepatitis (NASH): where are we now and where are we going?
Although non-alcoholic steatohepatitis (NASH) was considered relatively uncommon prior to the middle of the last decade, over the past three years there has been an explosion of studies on various ...
gut.bmj5d
Butyrate inhibits inflammatory responses through NFκB inhibition: implications for Crohn's disease
Professor J P Galmiche, Centre de Recherche en Nutrition Humaine, CRI INSERM 95-08, CHU, Hôtel Dieu, Place A Ricordeau, 44035 Nantes cedex 01, France. Email:galmiche{at}easynet.fr BACKGROUND/AIM ...
gut.bmj9d
An updated Asia Pacific Consensus Recommendations on colorectal cancer screening
Objective Since the publication of the first Asia Pacific Consensus on Colorectal Cancer (CRC) in 2008, there are substantial advancements in the science and experience of implementing CRC screening.
gut.bmj5d
Genetic evolution of pancreatic cancer: lessons learnt from the pancreatic cancer genome sequencing project
The Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA Correspondence to Christine A Iacobuzio-Donahue, Associate Professor of Pathology, ...